BHCM
KRRO icon

Brevan Howard Capital Management’s Korro Bio KRRO Stock Holding History

Brevan Howard Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,602
Closed -$324K – 1237
2024
Q1 		$324K Buy
+3,602
New +$197K ﹤0.01% 623

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brevan Howard Capital Management's KRRO Position: Q2 2024 in Review

Brevan Howard Capital Management sold out of Korro Bio (KRRO) in Q2 2024, closing a stake of 3,602 shares — an estimated $324K sold.

Brevan Howard Capital Management first reported a position in KRRO in Q1 2024 and held it in 1 quarter. The position peaked at $324K in Q1 2024. 64 funds tracked by Wall St. Rank hold KRRO as of Q2 2024.

  • Brevan Howard Capital Management reported no remaining Korro Bio position as of Q2 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 3,602 Korro Bio shares in Q2 2024, an estimated $324K.
  • Brevan Howard Capital Management first reported a position in Korro Bio in Q1 2024 and held it in 1 quarter.
  • Brevan Howard Capital Management's Korro Bio position peaked at $324K in Q1 2024.
  • 64 funds tracked by Wall St. Rank held Korro Bio as of Q2 2024.

Based on Brevan Howard Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.